Fexer, J; Donnachie, E; Schneider, A; Wagenpfeil, S; Keller, M; Hofmann, F; Mehring, M The effects of theophylline on hospital admissions and exacerbations in COPD patients—audit data from the Bavarian disease management program Dtsch Arztebl Int 2014; 111(17): ; DOI: /arztebl
Fexer, J; Donnachie, E; Schneider, A; Wagenpfeil, S; Keller, M; Hofmann, F; Mehring, M The effects of theophylline on hospital admissions and exacerbations in COPD patients—audit data from the Bavarian disease management program Dtsch Arztebl Int 2014; 111(17): ; DOI: /arztebl
Fexer, J; Donnachie, E; Schneider, A; Wagenpfeil, S; Keller, M; Hofmann, F; Mehring, M The effects of theophylline on hospital admissions and exacerbations in COPD patients—audit data from the Bavarian disease management program Dtsch Arztebl Int 2014; 111(17): ; DOI: /arztebl
Fexer, J; Donnachie, E; Schneider, A; Wagenpfeil, S; Keller, M; Hofmann, F; Mehring, M The effects of theophylline on hospital admissions and exacerbations in COPD patients—audit data from the Bavarian disease management program Dtsch Arztebl Int 2014; 111(17): ; DOI: /arztebl
Fexer, J; Donnachie, E; Schneider, A; Wagenpfeil, S; Keller, M; Hofmann, F; Mehring, M The effects of theophylline on hospital admissions and exacerbations in COPD patients—audit data from the Bavarian disease management program Dtsch Arztebl Int 2014; 111(17): ; DOI: /arztebl
Fexer, J; Donnachie, E; Schneider, A; Wagenpfeil, S; Keller, M; Hofmann, F; Mehring, M The effects of theophylline on hospital admissions and exacerbations in COPD patients—audit data from the Bavarian disease management program Dtsch Arztebl Int 2014; 111(17): ; DOI: /arztebl
Fexer, J; Donnachie, E; Schneider, A; Wagenpfeil, S; Keller, M; Hofmann, F; Mehring, M The effects of theophylline on hospital admissions and exacerbations in COPD patients—audit data from the Bavarian disease management program Dtsch Arztebl Int 2014; 111(17): ; DOI: /arztebl
Fexer, J; Donnachie, E; Schneider, A; Wagenpfeil, S; Keller, M; Hofmann, F; Mehring, M The effects of theophylline on hospital admissions and exacerbations in COPD patients—audit data from the Bavarian disease management program Dtsch Arztebl Int 2014; 111(17): ; DOI: /arztebl
Fexer, J; Donnachie, E; Schneider, A; Wagenpfeil, S; Keller, M; Hofmann, F; Mehring, M The effects of theophylline on hospital admissions and exacerbations in COPD patients—audit data from the Bavarian disease management program Dtsch Arztebl Int 2014; 111(17): ; DOI: /arztebl
Fexer, J; Donnachie, E; Schneider, A; Wagenpfeil, S; Keller, M; Hofmann, F; Mehring, M The effects of theophylline on hospital admissions and exacerbations in COPD patients—audit data from the Bavarian disease management program Dtsch Arztebl Int 2014; 111(17): ; DOI: /arztebl
Fexer, J; Donnachie, E; Schneider, A; Wagenpfeil, S; Keller, M; Hofmann, F; Mehring, M The effects of theophylline on hospital admissions and exacerbations in COPD patients—audit data from the Bavarian disease management program Dtsch Arztebl Int 2014; 111(17): ; DOI: /arztebl